AI Creates Drug for Lung Disease | Tech News

AI just made a breakthrough in drug discovery: Insilico Medicine’s rentosertib, designed to fight deadly idiopathic pulmonary fibrosis, is now in Phase Three trials. Discovered and built from scratch by AI systems PandaOmics and Chemistry42 in just 18 months, this new molecule shows early promise—patients on it gained lung capacity while placebo groups lost it. Safe, effective, and granted Orphan Drug status by the FDA, rentosertib’s late-stage trial could redefine how we develop life-saving medicines. This isn’t just speed—it’s proof AI can deliver real, human-impact treatments. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/3f3507becf9d2145